Ageing Research Reviews · Nov 21, 2026

Cellular Senescence as a Multiorgan Driver of Diabetes-Associated Cardiovascular and Kidney Disease

By Zhang H, Feng J, Zhu D et al.

Cellular senescence may contribute to persistent cardiovascular and kidney dysfunction in diabetes, but its effects depend on cell identity, tissue compartment and disease stage. This targeted narrative review integrates mechanistic, preclinical and early human evidence into a proposed multiorgan framework. Experimental studies support functional effects of senescent beta-cell, adipose, vascular and tubular populations, while predominantly post-mitotic cardiomyocytes and mature podocytes exhibit senescence-like states. Local paracrine mechanisms, including tubular-to-fibroblast signalling, are better established than source-specific transmission between distant organs. Adipose-derived extracellular vesicles provide an experimental adipose-to-heart example in diabetic mice, whereas the broader contributions of circulating SASP factors, metabolites and immune-cell trafficking remain incompletely resolved. We therefore present the diabetes–heart–kidney senescence loop as a conceptual interpretation of the available evidence, rather than a validated causal network. Senolytic and senomorphic interventions improve selected phenotypes in preclinical models. Major unresolved questions concern the pathogenic cell populations in patients, the direction and specificity of interorgan signalling, and the timing and safety of intervention. Clinical translation requires cell-resolved biomarkers and evidence that senescence-directed treatment adds functional benefit to established cardiometabolic care while preserving beneficial repair and immune functions.

doi.org/10.1016/j.arr.2026.103447PubMed 43067532Mechanisms

AgingResearch.News